Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Fred Dufour/AFP/Getty Images

The #2 story on the WashPost's homepage argues that based on the joint U.S.-China statement released Saturday, "China looks as if it's winning President Trump's trade skirmish — so far."

Be smart: Axios' Jonathan Swan analyzes the Trump administration's weekend trade moves on China in a pithy tweet, "The bark to bite ratio is currently about 85:1."

Here's the case by WaPo's economics correspondent Heather Long:

  • "Notice China didn't agree to a specific amount."
  • The statement was "brief and lackluster" on intellectual property theft.
  • Fox Business host Lou Dobbs: “Chinese say 'no deal.'"
  • "China's 'concessions' are things it planned to do anyway."
  • "The United States agreed to suspend tariffs."
  • "Zero curbs on China's high-tech plans."

"Trump’s tough-guy persona is taking a beating from China," says a story at the top of the Post's print front page, by David J. Lynch:

  • "The former business executive, who prides himself on his negotiating savvy, is facing criticism for bending to the Chinese government, ... alarming longtime supporters who had welcomed his call for a more confrontational approach to Beijing."
  • "Administration officials ... scrambled to cast the Chinese talks as a victory, while some staunch Trump supporters questioned whether Trump had blinked in the first major confrontation with China."

Go deeper: Swan examined this weekend announcements in-depth last night.

Go deeper

USAID chief tests positive for coronavirus

An Air Force cargo jet delivers USAID supplies to Russia earlier this year. Photo: Mikhail Metzel/TASS via Getty Images

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of senior administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Bryan Walsh, author of Future
3 hours ago - Health

COVID-19 shows a bright future for vaccines

Illustration: Annelise Capossela/Axios

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.

5 hours ago - Health

Beware a Thanksgiving mirage

Illustration: Sarah Grillo/Axios

Don't be surprised if COVID metrics plunge over the next few days, only to spike next week.

Why it matters: The COVID Tracking Project warns of a "double-weekend pattern" on Thanksgiving — where the usual weekend backlog of data is tacked on to a holiday.